GILD240426P00072000 Option on Gilead Sciences
| GILD Stock | USD 64.78 0.55 0.84% |
Gilead Sciences' option chain provides insight into all available option contracts written on Gilead Sciences' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Gilead Sciences' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Gilead option contract.
In The Money vs. Out of Money Option Contracts on Gilead Sciences
Analyzing Gilead Sciences' in-the-money options over time can help investors to take a profitable long position in Gilead Sciences regardless of its overall volatility. This is especially true when Gilead Sciences' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Gilead Sciences' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Gilead Sciences' stock while costing only a fraction of its price.
Gilead Sciences' latest option contracts expiring on 2024-05-10 are carrying combined implied volatility of 20.39 with a put-to-call open interest ratio of 0.78 over 78 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on 2024-05-10. The current put volume is at 394, with calls trading at the volume of 2338. This yields a 0.17 put-to-call volume ratio. The Gilead Sciences option chain provides detailed quote and price information for the current Gilead Sciences option contracts. It shows all of Gilead Sciences' listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-05-10 Option Contracts
Gilead Sciences option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Gilead Sciences' lending market. For example, when Gilead Sciences' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Gilead Sciences, he or she must hedge the risk by shorting Gilead Sciences stock over its option's life.
2024-05-10
The chart above shows Gilead Sciences' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Gilead Sciences' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Gilead Sciences' option, there is no secondary market available for investors to trade.
Gilead Sciences Maximum Pain Price across 2024-05-10 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Gilead Sciences close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Gilead Sciences' stock options are financial instruments that give investors the right to buy or sell shares of Gilead Sciences common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Gilead stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Gilead Sciences' stock price goes up or down, the stock options follow.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. Please note that buying 'in-the-money' options on Gilead Sciences lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Gilead Sciences' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Gilead Sciences contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Gilead Stock moves the wrong way.
At present, Gilead Sciences' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 65.2 B, whereas Common Stock Total Equity is forecasted to decline to about 892.4 K. Gilead Sciences In The Money Call Balance
When Gilead Sciences' strike price is surpassing the current stock price, the option contract against Gilead Sciences stock is said to be in the money. When it comes to buying Gilead Sciences' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Gilead Sciences are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Gilead Current Options Market Mood
Gilead Sciences' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Gilead Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Gilead Sciences' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Gilead Sciences' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Gilead Sciences' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Gilead contract
Base on the Rule 16, the options market is currently suggesting that Gilead Sciences will have an average daily up or down price movement of about 1.27% per day over the life of the 2024-05-10 option contract. With Gilead Sciences trading at USD 64.78, that is roughly USD 0.83. If you think that the market is fully incorporating Gilead Sciences' daily price movement you should consider buying Gilead Sciences options at the current volatility level of 20.39%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Gilead |
Purchasing Gilead Sciences options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Gilead calls. Remember, the seller must deliver Gilead Sciences stock to the call owner when a call is exercised.
Gilead Sciences Option Chain
When Gilead Sciences' strike price is surpassing the current stock price, the option contract against Gilead Sciences stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
2024-05-102024-05-172024-05-242024-05-312024-06-072024-06-142024-06-212024-07-192024-08-162024-11-152025-01-172025-06-202026-01-16
Gilead Sciences' option chain is a display of a range of information that helps investors for ways to trade options on Gilead. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Gilead. It also shows strike prices and maturity days for a Gilead Sciences against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-05-10 CALL at $45.0 | 0.9302 | 0.0076 | 0 | 2024-05-10 | 19.3 - 21.45 | 0.0 | In |
Call | 2024-05-10 CALL at $50.0 | 0.9634 | 0.0081 | 0 | 2024-05-10 | 13.15 - 16.7 | 0.0 | In |
Call | 2024-05-10 CALL at $53.0 | 0.9806 | 0.0072 | 0 | 2024-05-10 | 11.65 - 12.0 | 0.0 | In |
Call | 2024-05-10 CALL at $54.0 | 0.9714 | 0.0102 | 0 | 2024-05-10 | 10.7 - 11.0 | 0.0 | In |
Call | 2024-05-10 CALL at $55.0 | 0.8893 | 0.0205 | 0 | 2024-05-10 | 9.65 - 10.95 | 0.0 | In |
Call | 2024-05-10 CALL at $56.0 | 0.8721 | 0.0236 | 0 | 2024-05-10 | 8.6 - 10.15 | 0.0 | In |
Call | 2024-05-10 CALL at $57.0 | 0.9115 | 0.0251 | 0 | 2024-05-10 | 7.65 - 8.45 | 0.0 | In |
Call | 2024-05-10 CALL at $58.0 | 0.825 | 0.0313 | 0 | 2024-05-10 | 6.6 - 8.6 | 0.0 | In |
Call | 2024-05-10 CALL at $59.0 | 0.9671 | 0.0217 | 0 | 2024-05-10 | 5.7 - 5.95 | 0.0 | In |
Call | 2024-05-10 CALL at $60.0 | 0.9077 | 0.043 | 0 | 2024-05-10 | 3.75 - 4.95 | 0.0 | In |
Call | 2024-05-10 CALL at $61.0 | 0.8758 | 0.0591 | 2 | 2024-05-10 | 2.53 - 4.0 | 4.76 | In |
Call | 2024-05-10 CALL at $62.0 | 0.9098 | 0.0753 | 4 | 2024-05-10 | 2.76 - 2.99 | 2.6 | In |
Call | 2024-05-10 CALL at $63.0 | 0.7889 | 0.1252 | 2 | 2024-05-10 | 1.9 - 2.23 | 1.76 | In |
Call | 2024-05-10 CALL at $64.0 | 0.6732 | 0.1984 | 15 | 2024-05-10 | 1.13 - 1.23 | 0.96 | In |
Call | 2024-05-10 CALL at $65.0 | 0.4553 | 0.2323 | 234 | 2024-05-10 | 0.54 - 0.62 | 0.58 | Out |
Call | 2024-05-10 CALL at $66.0 | 0.234 | 0.1882 | 324 | 2024-05-10 | 0.21 - 0.26 | 0.22 | Out |
Call | 2024-05-10 CALL at $67.0 | 0.1009 | 0.1046 | 466 | 2024-05-10 | 0.07 - 0.09 | 0.08 | Out |
Call | 2024-05-10 CALL at $68.0 | 0.0415 | 0.0495 | 107 | 2024-05-10 | 0.02 - 0.05 | 0.03 | Out |
Call | 2024-05-10 CALL at $69.0 | 0.0257 | 0.0287 | 234 | 2024-05-10 | 0.0 - 0.03 | 0.02 | Out |
Call | 2024-05-10 CALL at $72.0 | 0.0348 | 0.0207 | 62 | 2024-05-10 | 0.0 - 0.04 | 0.05 | Out |
Put | 2024-05-10 PUT at $61.0 | -0.0346 | 0.0353 | 13 | 2024-05-10 | 0.01 - 0.05 | 0.05 | Out |
Put | 2024-05-10 PUT at $62.0 | -0.0764 | 0.0712 | 30 | 2024-05-10 | 0.04 - 0.08 | 0.07 | Out |
Put | 2024-05-10 PUT at $63.0 | -0.1559 | 0.1316 | 81 | 2024-05-10 | 0.12 - 0.16 | 0.15 | Out |
Put | 2024-05-10 PUT at $64.0 | -0.3153 | 0.2099 | 259 | 2024-05-10 | 0.31 - 0.35 | 0.35 | Out |
Put | 2024-05-10 PUT at $65.0 | -0.5491 | 0.2521 | 421 | 2024-05-10 | 0.67 - 0.8 | 0.74 | In |
Put | 2024-05-10 PUT at $66.0 | -0.7462 | 0.1803 | 215 | 2024-05-10 | 1.32 - 2.11 | 1.48 | In |
Put | 2024-05-10 PUT at $67.0 | -0.7866 | 0.109 | 152 | 2024-05-10 | 2.14 - 2.53 | 2.14 | In |
Put | 2024-05-10 PUT at $68.0 | -0.8873 | 0.0752 | 145 | 2024-05-10 | 2.24 - 3.35 | 3.57 | In |
Put | 2024-05-10 PUT at $69.0 | -0.8291 | 0.0611 | 5 | 2024-05-10 | 4.1 - 4.65 | 4.58 | In |
Put | 2024-05-10 PUT at $70.0 | -0.9366 | 0.0421 | 24 | 2024-05-10 | 4.65 - 5.95 | 4.7 | In |
Put | 2024-05-10 PUT at $71.0 | -0.7851 | 0.0416 | 0 | 2024-05-10 | 6.15 - 7.9 | 5.1 | In |
Put | 2024-05-10 PUT at $72.0 | -0.8753 | 0.0359 | 0 | 2024-05-10 | 5.9 - 7.55 | 6.05 | In |
Put | 2024-05-10 PUT at $73.0 | -0.9623 | 0.0192 | 2 | 2024-05-10 | 8.15 - 8.4 | 8.22 | In |
Put | 2024-05-10 PUT at $74.0 | -0.9006 | 0.0271 | 0 | 2024-05-10 | 7.9 - 9.5 | 7.0 | In |
Put | 2024-05-10 PUT at $75.0 | -0.8482 | 0.0271 | 0 | 2024-05-10 | 10.1 - 11.6 | 6.8 | In |
Put | 2024-05-10 PUT at $76.0 | -0.9525 | 0.0164 | 0 | 2024-05-10 | 11.15 - 11.5 | 0.0 | In |
Put | 2024-05-10 PUT at $77.0 | -0.9145 | 0.02 | 0 | 2024-05-10 | 10.45 - 12.5 | 0.0 | In |
Put | 2024-05-10 PUT at $78.0 | -0.8929 | 0.0201 | 0 | 2024-05-10 | 11.6 - 13.65 | 11.0 | In |
Put | 2024-05-10 PUT at $79.0 | -0.8324 | 0.0206 | 0 | 2024-05-10 | 14.15 - 16.25 | 12.7 | In |
Put | 2024-05-10 PUT at $80.0 | -0.7926 | 0.0195 | 0 | 2024-05-10 | 13.35 - 16.75 | 8.9 | In |
Put | 2024-05-10 PUT at $81.0 | -0.9616 | 0.0105 | 0 | 2024-05-10 | 15.3 - 17.35 | 0.0 | In |
Put | 2024-05-10 PUT at $82.0 | -0.8205 | 0.0177 | 0 | 2024-05-10 | 15.35 - 18.5 | 0.0 | In |
Put | 2024-05-10 PUT at $83.0 | -0.896 | 0.0152 | 0 | 2024-05-10 | 16.35 - 18.75 | 0.0 | In |
Put | 2024-05-10 PUT at $84.0 | -0.8986 | 0.0144 | 0 | 2024-05-10 | 17.35 - 19.75 | 0.0 | In |
Put | 2024-05-10 PUT at $85.0 | -0.9424 | 0.0109 | 0 | 2024-05-10 | 19.65 - 21.25 | 0.0 | In |
Put | 2024-05-10 PUT at $90.0 | -0.9749 | 0.0056 | 0 | 2024-05-10 | 23.4 - 27.2 | 0.0 | In |
Put | 2024-05-10 PUT at $95.0 | -0.9772 | 0.0046 | 0 | 2024-05-10 | 28.4 - 32.2 | 0.0 | In |
Put | 2024-05-10 PUT at $100.0 | -0.989 | 0.0024 | 0 | 2024-05-10 | 33.35 - 37.15 | 0.0 | In |
Put | 2024-05-10 PUT at $105.0 | -0.9723 | 0.0041 | 0 | 2024-05-10 | 38.4 - 42.3 | 0.0 | In |
Gilead Sciences Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
Gilead Sciences Common Stock Shares Outstanding Over Time
The total number of shares of a company's common stock that are currently owned by all its shareholders. Common Stock Shares Outstanding |
| Timeline |
Gilead Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in Gilead Sciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Gilead Sciences Corporate Management
Elected by the shareholders, the Gilead Sciences' board of directors comprises two types of representatives: Gilead Sciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Gilead. The board's role is to monitor Gilead Sciences' management team and ensure that shareholders' interests are well served. Gilead Sciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Gilead Sciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Johanna Mercier | Chief Commercial Officer | Profile | |
| Deborah Telman | General Affairs | Profile | |
| Jacquie CFA | Vice Relations | Profile | |
| Diane Wilfong | Corp VP | Profile | |
| Flavius MD | Executive Research | Profile |
Already Invested in Gilead Sciences?
The danger of trading Gilead Sciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Gilead Sciences is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Gilead Sciences. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Gilead Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Gilead Sciences is a strong investment it is important to analyze Gilead Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Gilead Sciences' future performance. For an informed investment choice regarding Gilead Stock, refer to the following important reports: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Gilead Stock analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Gilead Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.13) | Dividend Share 3.02 | Earnings Share 0.36 | Revenue Per Share 22 | Quarterly Revenue Growth 0.053 |
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.